Compare Alliant Energy Corporation (LNT) vs Twist Bioscience Corp (TWST) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Alliant Energy Corporation vs Twist Bioscience Corp — how do they compare? Alliant Energy Corporation trades at $73.98 (market cap $19.10B), while Twist Bioscience Corp trades at $88.31 (market cap $5.45B). The key difference: Alliant Energy Corporation is far larger — about 3.5× Twist Bioscience Corp's market cap, and Alliant Energy Corporation pays a 2.89% dividend while Twist Bioscience Corp pays none. Which is the better fit depends on your goals.
| LNT | TWST | |
|---|---|---|
Market Cap | $19.10B | $5.45B |
Sector | Utilities | Health |
52-Week High | $78.03 | $102.88 |
52-Week Low | $63.62 | $24.16 |
Enterprise Value | $30.83B | $5.37B |
Dividend Yield | 2.89% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Alliant Energy (LNT) trades at $73.11, down 2.29% on the day, with a bullish technical outlook and strong analyst support. The stock shows steady revenue growth, improving net income margins to 18.58% in 2025, and consistent dividend payments. Recent news highlights its $13.4 billion clean energy investment plan targeting 5-7% annual earnings growth, driven by data center demand and grid modernization initiatives.
LNT presents a favorable risk-reward profile with a consensus price target of $78.50, offering 7.4% upside. Key risks include rising debt levels and execution of capital-intensive projects. The bullish analyst consensus (52% Buy) and institutional confidence support long-term growth, though investors should monitor interest rate sensitivity and regulatory developments.
TWST trades at $95.86, up 2.14% today, with a bullish technical signal and strong institutional interest. Revenue growth is robust, rising from $204M in 2022 to $377M in 2025, though the company remains unprofitable with a net income margin of -19.85%. Recent news highlights AI-driven collaborations and earnings beats, but cash flow trends show persistent operational losses.
The outlook is mixed; analyst consensus is bullish with a $91.63 price target, but profitability challenges and negative cash flows pose significant risks. Investment opportunity lies in continued revenue expansion and AI partnerships, while execution risks and high valuations require caution.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Alliant Energy Corporation
Alliant Energy is the parent of two regulated utilities, Interstate Power and Light and Wisconsin Power and Light, serving nearly 1 million electricity and natural gas customers and approximately 420,000 natural gas-only customers. Both subsidiaries engage in the generation and distribution of electricity and the distribution and transportation of natural gas. Alliant also owns a 16% interest in American Transmission Co.
Read more on LNT →About Twist Bioscience Corp
Twist Bioscience Corp is a synthetic biology company. It develops a disruptive DNA synthesis platform to industrialize the engineering of biology. The company's DNA synthesis platform utilizes a proprietary semiconductor-based synthetic DNA manufacturing process that synthesizes DNA on silicon instead of on traditional well plastic plates to enable the production of high-quality synthetic DNA faster and affordable as well as overcomes inefficiencies. Powering cost-effective, rapid high-throughput synthesis, it enables researchers to rapidly realize opportunities ahead. Geographically, it derives a majority of revenue from the United States.
Read more on TWST →
